Information Provided By:
Fly News Breaks for April 11, 2016
CELG
Apr 11, 2016 | 07:40 EDT
After hosting doctor panel discussions, RBC Capital reports that doctors were "eagerly awaiting" Celgene's ulcerated colitis treatment, Ozanimod, "as an oral option that should be at least as good as injectables." According to the firm, doctors were "optimistic and hopeful" that good endoscopy data on the company's GED-0301 treatment for Crohn's would "confirm its very strong initial efficacy."
News For CELG From the Last 2 Days
There are no results for your query CELG